News

Regeneron Pharmaceuticals, Inc. (REGN) Q3 2023 Earnings Call Transcript

36 Mins read

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET

Company Participants

Ryan Crowe – Vice President-Investor Relations

Leonard Schleifer – President and Chief Executive Officer

George Yancopoulos – President and Chief Scientific Officer

Marion McCourt – Executive Vice President and Head-Commercial

Bob Landry – Executive Vice President and Chief Financial Officer

Conference Call Participants

Evan Seigerman – BMO Capital Markets

Mohit Bansal – Wells Fargo

Chris Raymond – Piper Sandler

Colin Bristow – UBS

Tyler Van Buren – TD Cowen

Carter Gould – Barclays

Robyn Karnauskas – Truist Securities

Salveen Richter – Goldman Sachs

Brian Abrahams – RBC Capital Markets

Yatin Suneja – Guggenheim

Dane Leone – Raymond James

Brian Skorney – Baird

Operator

Welcome to the Regeneron Pharmaceuticals Third Quarter 2023 Earnings Conference Call. My name is Shannon, and I will be your operator for today’s call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please note that this conference is being recorded.

I will now turn the call over to Ryan Crowe, Vice President, Investor Relations. You may begin.

Ryan Crowe

Thank you, Shannon. Good morning, good afternoon and good evening to everyone listening around the world. Thank you for your interest in Regeneron and welcome to our third quarter 2023 earnings conference call. An archive and transcript of this webcast will be available on our Investor Relations website shortly after the call ends.

Joining me on today’s call are Dr. Leonard Schleifer, Board Co-Chair, Co-Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Board Co-Chair, Co-Founder, President and Chief Scientific Officer; Marion McCourt, Executive Vice President and Head of Commercial; and Bob Landry, Executive Vice President and Chief Financial Officer. After our prepared remarks, we will open the call for Q&A.

I

Read the full article here

Related posts
News

Philip Morris Stock Appears Overvalued Compared To Peers (NYSE:PM)

1 Mins read
This article was written by Follow Philipp is a seasoned value investor with nearly 20 years of experience in the field. He…
News

Imperial Brands: Resilient Market Performance And A Strong Cash Flow Yield (OTCMKTS:IMBBY)

1 Mins read
This article was written by Follow I have more than five years experience in the financial industry. I focus mostly in the…
News

Nature's Sunshine Products, Inc. (NATR) Q4 2024 Earnings Call Transcript

1 Mins read
Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Q4 2024 Results Conference Call March 11, 2025 5:00 PM ET Company Participants Nate Brower – General…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *